2026 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 3017628
E. Ellebaek, M. Weichenthal, I. Gavrilova, N. Asher, P. Terheyden, J. Utikal, A. J. Suljeviić, C. Pföhler, I. Stojkovski, R. A. Herbst, et al., “Efficacy of combined BRAF-MEK inhibitor second-line therapy in patients with non-resectable or metastatic BRAFV600-positive melanoma after prior immunotherapy: A retrospective EUMelaReg multicenter study”, EJC Skin Cancer, 2026, 4, : 100773.
PUB |
DOI |
WoS